XCL1 and neuropathy: Our results demonstrated for the first time the upregulation in the level of XCL1 mRNA/protein during neuropathy development (already one day after CCI), which was maintained for up to 35 days, and as revealed by confocal analysis of immunofluorescent staining, these chemokines are produced mainly by spinal astroglial cells.